胃腸支架市場規模、佔有率、成長分析、按產品、按材料、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

2022年全球胃腸支架市場規模為4.432億美元，從2023年的4.6713億美元成長到2031年的7.1148億美元，預計在預測期內（2024-2031年）將以年複合成長率成長。為5.4%）。

由於胃腸道疾病盛行率上升和人口老化，全球胃腸道支架市場正在強勁成長。由於生活方式的改變、不良的飲食習慣和肥胖率的上升，大腸直腸癌和發炎性腸道疾病腸道疾病等疾病呈上升趨勢。因此，對胃腸支架的需求不斷增加，因為它們提供了有效的微創治療方法，可以改善患者的生活品質。老年人更容易受到與老齡化相關的胃腸道問題的影響，並且更喜歡支架等侵入性較小的選擇，這一事實進一步推動了市場的發展。自膨脹金屬支架 (SEMS) 和生物分解性支架等創新正在改善治療效果和患者舒適度，並推動市場擴張。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及前景

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析

胃腸支架市場規模：依產品及年複合成長率（2024-2031）

• 市場概況
• 膽管支架
• 十二指腸支架
• 結腸支架
• 胰臟支架
• 食道支架

胃腸支架市場規模：依材料及年複合成長率（2024-2031）

• 市場概況
• 自膨式金屬支架
• 鎳鈦諾
• 塑膠支架
• 其他

胃腸支架市場規模：依應用與年複合成長率（2024-2031）

• 市場概況
• 膽道疾病
• 大腸激躁症
• 消化道癌症
• 大腸直腸癌
• 胃癌
• 食道癌
• 胰臟癌

胃腸支架市場規模：依最終用戶及年複合成長率（2024-2031）

• 市場概況
• 醫院和診所
• 門診手術中心

胃腸支架市場規模及年複合成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
• 產品系列分析
• 按細分市場分類的佔有率分析
• 收益與前一年同期比較（2021-2023）

主要企業簡介

• 波士頓科學公司（美國）
• BD（貝克頓迪金森公司）（美國）
• 庫克醫療（美國）
• 奧林巴斯公司（日本）
• Merit 醫療系統（美國）
• CONMED公司（美國）
• ELLA-CS sro（捷克共和國）
• 霍布斯醫療公司（美國）
• 泰熊醫療有限公司（韓國）
• S&G BIoTech Inc.（韓國）
• 美敦力（愛爾蘭）
• 艾伯維（美國）
• 強生公司（美國）
• 武田藥品工業株式會社（日本）
• 輝瑞公司（美國）
• 諾華公司（瑞士）
• 拜耳公司（德國）
• 阿斯特捷利康公司（英國）
• 羅氏控股公司（瑞士）
• 禮來公司（美國）

結論和建議

Global Gastrointestinal Stents Market size was valued at USD 443.2 million in 2022 and is poised to grow from USD 467.13 million in 2023 to USD 711.48 million by 2031, growing at a CAGR of 5.4% during the forecast period (2024-2031).

The global gastrointestinal stents market is witnessing robust growth, fueled by the escalating prevalence of gastrointestinal disorders and an aging population. Lifestyle changes, poor dietary habits, and rising obesity rates have led to an increase in conditions such as colorectal cancer and inflammatory bowel diseases. Consequently, the demand for gastrointestinal stents is on the rise, as they provide effective, less invasive treatment alternatives that enhance patient quality of life. The market is further bolstered by the elderly demographic, which is more susceptible to age-related gastrointestinal issues, fostering a preference for minimally invasive options like stents. Innovations such as self-expandable metal stents (SEMS) and biodegradable variants are transforming the landscape, offering improved outcomes and patient comfort, thereby driving market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gastrointestinal Stents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gastrointestinal Stents Market Segmental Analysis

Global Gastrointestinal Stents Market is segmented by products, material, application, end users and region. Based on products, the market is segmented into biliary stents, duodenal stents, colonic stents, pancreatic stents and esophageal stents. Based on material, the market is segmented into self-expanding metal stents, nitinol, plastic stents and others. Based on application, the market is segmented into biliary diseases, irritable bowel syndrome, gastrointestinal cancers, colorectal cancer, stomach cancer, esophageal cancer and pancreatic cancer. Based on end users, the market is segmented into hospitals and clinics and ambulatory surgical centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Gastrointestinal Stents Market

The Global Gastrointestinal Stents market is significantly driven by heightened awareness among patients and healthcare providers regarding the advantages of gastrointestinal stenting. This increased knowledge facilitates earlier diagnoses and timely medical interventions, which are crucial for effective treatment. Additionally, advancements in healthcare access, particularly in developing regions, have led to a rise in the adoption of stenting procedures. As more individuals gain access to quality healthcare services and understand the effectiveness of these stents, the overall demand in the market continues to grow, contributing to its ongoing expansion and evolution.

Restraints in the Global Gastrointestinal Stents Market

One significant restraint affecting the Global Gastrointestinal Stents market is the presence of limited reimbursement policies in certain regions. These policies can impose strict criteria on procedures involving gastrointestinal stents, which can significantly impact the affordability and accessibility of these treatments for patients. As a result, the financial burden on healthcare providers and patients can restrict the adoption of stent-based therapies, ultimately obstructing the overall growth and development of the market. Consequently, these reimbursement challenges may deter healthcare practitioners from recommending stent procedures, further limiting the potential market expansion.

Market Trends of the Global Gastrointestinal Stents Market

The global gastrointestinal stents market is witnessing a notable trend towards the adoption of biodegradable stents, driven by their clear advantages over traditional metallic alternatives. These innovative stents are designed to dissolve gradually, eliminating the need for invasive removal procedures, thus enhancing patient convenience and safety. As healthcare providers increasingly emphasize patient-centered care, the demand for biodegradable options is growing, reflecting a shift towards more effective and less invasive treatment methodologies. Additionally, biodegradable stents support the healing process by providing temporary structural integrity, making them a preferred choice for both clinicians and patients. This trend signifies a transformative phase within the gastrointestinal stent market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Gastrointestinal Stents Market Size by Products & CAGR (2024-2031)

• Market Overview
• Biliary Stents
• Duodenal Stents
• Colonic Stents
• Pancreatic Stents
• Esophageal Stents

Global Gastrointestinal Stents Market Size by Material & CAGR (2024-2031)

• Market Overview
• Self-Expanding Metal Stents
• Nitinol
• Plastic Stents
• Others

Global Gastrointestinal Stents Market Size by Application & CAGR (2024-2031)

• Market Overview
• Biliary Diseases
• Irritable Bowel Syndrome
• Gastrointestinal Cancers
• Colorectal Cancer
• Stomach Cancer
• Esophageal Cancer
• Pancreatic Cancer

Global Gastrointestinal Stents Market Size by End Users & CAGR (2024-2031)

• Market Overview
• Hospitals and Clinics
• Ambulatory Surgical Centers

Global Gastrointestinal Stents Market Size & CAGR (2024-2031)

• North America (Products, Material, Application, End Users)
  • USA
  • Canada
• Europe (Products, Material, Application, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Products, Material, Application, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Products, Material, Application, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Products, Material, Application, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CONMED Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ELLA-CS s.r.o. (Czech Republic)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hobbs Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taewoong Medical Co. Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• S&G Biotech Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations